CHARACTERISTICS AND MANAGEMENT OF MIGRAINE PATIENTS WHO HAVE FAILED PRIOR PREVENTIVE TREATMENT IN PORTUGAL

被引：0
|
作者：
Silva, C. [1 ]
Vo, P. [2 ]
Carboni, V [3 ]
Quintana, R. [4 ]
Monge, S. [1 ]
Laires, P. A. [1 ]
机构：
[1] Novartis Farma, Porto Salvo, Portugal
[2] Novartis Pharma AG, Basel, Switzerland
[3] GfK Hlth, Basel, Switzerland
[4] GfK, Madrid, Spain
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.2106
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND141
引用
收藏
页码：S353 / S353
页数：1
相关论文
共 50 条
  • [41] MITOMYCIN FOR PATIENTS WHO HAVE FAILED ON THIOTEPA
    KOONTZ, WW
    HENEY, NM
    SOLOWAY, MS
    KLUSKENS, L
    HAZRA, TA
    TRUMP, DL
    BARTON, B
    [J]. UROLOGY, 1985, 26 (04) : 30 - 31
  • [42] Differences between patients who have vestibular migraine and those who have migraine without vertigo
    Ozcelik, P.
    Kocoglu, K.
    Akdal, G.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 926 - 926
  • [43] The role of laparoscopic treatment of endometriosis in patients who have failed in vitro fertilization
    Littman, ED
    Milki, AA
    Nezhat, CR
    [J]. FERTILITY AND STERILITY, 2004, 81 : S25 - S26
  • [44] The effect of oxygen therapy in patients who have failed surgical treatment for OSA
    Joosten, S. A.
    Tan, M.
    Wong, A-M.
    Landry, S.
    Turton, A.
    Stonehouse, J.
    Hamilton, G. S.
    Edwards, B. A.
    [J]. JOURNAL OF SLEEP RESEARCH, 2019, 28
  • [45] CHARACTERISTICS OF PATIENTS WITH CHRONIC HEPATITIS C WHO HAVE FAILED PAST TREATMENT OR WHO HAVE NEVER BEEN TREATED: HOW MUCH ROOM LEFT FOR INTERFERON?
    Ciaccio, A.
    Okolicsanyi, S.
    Rota, M.
    Cortesi, P. A.
    De Salvia, S.
    Gemma, M.
    Vinci, M.
    Mantovani, L. G.
    Belli, L. S.
    Strazzabosco, M.
    [J]. DIGESTIVE AND LIVER DISEASE, 2015, 47 : E58 - E58
  • [46] Characteristics of Patients Receiving Preventive Treatment Among Prevention-eligible Patients with Migraine
    Foster, S. A.
    Nguyen, J. L.
    Carpinella, C.
    Nicholson, R. A.
    Mason, O.
    Ye, W.
    [J]. HEADACHE, 2019, 59 : 125 - 125
  • [47] Long-term Efficacy of Erenumab in Patients With Chronic Migraine Who Failed ≥3 Prior Prophylactic Treatments
    Weatherall, Mark
    Gantenbein, Andreas R.
    Ritter, Shannon
    Snellman, Josefin
    Klatt, Jan
    Mikol, Daniel D.
    [J]. CEPHALALGIA, 2019, 39 : 240 - 241
  • [48] PREVENTIVE TREATMENT OF CHRONIC MIGRAINE WITH ZONISAMIDE: A STUDY IN PATIENTS WHO ARE REFRACTORY OR INTOLERANT TO TOPIRAMATE
    Pascual-Gomez, J.
    Alana-Garcia, M.
    Oterino, A.
    Leira-Muino, R.
    Lainez-Andres, J. M.
    [J]. REVISTA DE NEUROLOGIA, 2008, 47 (09) : 449 - 451
  • [49] A Clinical Analysis of Secondary Surgery in Trigeminal Neuralgia Patients Who Failed Prior Treatment
    Kang, Il Ho
    Park, Bong Jin
    Park, Chang Kyu
    Malla, Hridayesh Pratap
    Lee, Sung Ho
    Rhee, Bong Arm
    [J]. JOURNAL OF KOREAN NEUROSURGICAL SOCIETY, 2016, 59 (06) : 637 - 642
  • [50] RETROSPECTIVE STUDY OF USING CARMUSTINE OR LOMUSTINE WITH BEVACIZUMAB IN RECURRENT GLIOBLASTOMA PATIENTS WHO HAVE FAILED PRIOR
    Rahman, Rifaquat
    Hempfling, Kelly
    Norden, Andrew
    Reardon, David A.
    Nayak, Lakshmi
    Rinne, Mikael
    Doherty, Lisa
    Ruland, Sandra
    Rai, Arun
    Rifenburg, Jennifer
    LaFrankie, Debra
    Wen, Patrick
    Lee, Eudocia
    [J]. NEURO-ONCOLOGY, 2013, 15 : 126 - 127
12345